Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
2 Personalized Program Design Based on your health profile, we develop a personalized wellness plan that may include medical weight loss, hormone optimization, recovery therapies, or body composition support
Mesotherapy or injections: why this is not DIY Some clinics use GHK-Cu in mesotherapy plans for the face or scalp, yet this route adds more risk than topical use, since it involves needles, sterile technique, and careful planning
Obesity among Health-Care Workers: Which Occupations Are at Higher Risk of Being Obese
Key Takeaways TRIUMPH-4 Phase 3 results (December 2025): 28.7% average body weight loss at 68 weeks on the 12mg dose vs 2.1% on placebo TRIUMPH program scope: Over 5,800 participants across four core trials covering obesity, type 2 diabetes, cardiovascular outcomes, and knee osteoarthritis Additional trials enrolling (April 2026): TRIUMPH-7, -8, and -9 are actively recruiting at Lilly trial sites How to enroll: Search ClinicalTrials.gov for retatrutide or call Lilly at 1-877-CTLILLY Retatrutide is investigational: Not FDA-approved as of April 2026
US$ 25.97
US$ 27.07
US$ 22.46
US$ 26.51
US$ 21.22
